NCT00035282View on ClinicalTrials.gov

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)

PHASE3CompletedINTERVENTIONAL
Enrollment

450

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions
Major Depressive Disorder
Interventions
DRUG

aprepitant

DRUG

Comparator: placebo (unspecified)

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00035282 - Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED) | Biotech Hunter | Biotech Hunter